政策红利不断释放,国内创新药行业或将“井喷”

制药网
Jun 18, 2025

【制药网 行业动态】2025 年,注定是创新药行业不平凡的一年,政策落地的转折如同春风化雨,催生出创新药板块企业股价的暴涨奇迹。​截至 2025 年 6 月,港股 18A 板块成为这场盛宴的焦点之一。在 53 家生物科技企业中,竟有 25 家股价年内翻倍。信达生物市值更是强势突破 1200 亿港元大关,荣昌生物、加科思等企业也毫不逊色,涨幅均超 200%。​而在 A 股市场,创新药板块同样活力四射...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10